This company listing is no longer active
Osmozis Balance Sheet Health
Financial Health criteria checks 3/6
Osmozis has a total shareholder equity of €16.0M and total debt of €14.2M, which brings its debt-to-equity ratio to 89%. Its total assets and total liabilities are €34.9M and €19.0M respectively. Osmozis's EBIT is €2.1M making its interest coverage ratio 2. It has cash and short-term investments of €5.5M.
Key information
89.0%
Debt to equity ratio
€14.22m
Debt
| Interest coverage ratio | 2x |
| Cash | €5.54m |
| Equity | €15.98m |
| Total liabilities | €18.97m |
| Total assets | €34.95m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 9VL's short term assets (€12.0M) exceed its short term liabilities (€6.1M).
Long Term Liabilities: 9VL's short term assets (€12.0M) do not cover its long term liabilities (€12.8M).
Debt to Equity History and Analysis
Debt Level: 9VL's net debt to equity ratio (54.3%) is considered high.
Reducing Debt: 9VL's debt to equity ratio has reduced from 131.2% to 89% over the past 5 years.
Debt Coverage: 9VL's debt is well covered by operating cash flow (28%).
Interest Coverage: 9VL's interest payments on its debt are not well covered by EBIT (2x coverage).